Phreesia Net Profit Margin 2019-2024 | PHR

Phreesia net profit margin from 2019 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Phreesia Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-01-31 $0.36B $-0.14B -38.66%
2023-10-31 $0.34B $-0.15B -42.77%
2023-07-31 $0.32B $-0.15B -47.81%
2023-04-30 $0.30B $-0.16B -53.97%
2023-01-31 $0.28B $-0.18B -62.63%
2022-10-31 $0.26B $-0.18B -70.23%
2022-07-31 $0.25B $-0.18B -73.47%
2022-04-30 $0.23B $-0.16B -68.86%
2022-01-31 $0.21B $-0.12B -54.93%
2021-10-31 $0.20B $-0.08B -40.10%
2021-07-31 $0.18B $-0.05B -27.93%
2021-04-30 $0.16B $-0.03B -19.63%
2021-01-31 $0.15B $-0.03B -18.24%
2020-10-31 $0.14B $-0.02B -16.55%
2020-07-31 $0.13B $-0.02B -13.43%
2020-04-30 $0.13B $-0.08B -63.85%
2020-01-31 $0.13B $-0.09B -73.60%
2019-07-31 $0.08B $-0.10B -117.86%
2019-04-30 $0.08B $-0.04B -51.28%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.185B $0.356B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.723B 19.61
Inspire Medical Systems (INSP) United States $7.393B 0.00
IRhythm Technologies (IRTC) United States $3.477B 0.00
Axonics (AXNX) United States $3.412B 0.00
10x Genomics (TXG) United States $3.208B 0.00
Enovis (ENOV) United States $3.038B 23.08
Azenta (AZTA) United States $2.905B 236.82
Olink Holding AB (publ) (OLK) Sweden $2.820B 0.00
Hims & Hers Health (HIMS) United States $2.680B 0.00
Privia Health (PRVA) United States $2.139B 94.89
Schrodinger (SDGR) United States $1.827B 0.00
Omnicell (OMCL) United States $1.248B 30.53
Definitive Healthcare (DH) United States $0.821B 0.00
Standard BioTools (LAB) United States $0.737B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.680B 0.00
Fulgent Genetics (FLGT) United States $0.619B 0.00
Talkspace (TALK) United States $0.536B 0.00
Health Catalyst (HCAT) United States $0.373B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.329B 0.00
Clover Health Investments (CLOV) United States $0.318B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
P3 Health Partners (PIII) United States $0.183B 0.00
Butterfly Network (BFLY) United States $0.164B 0.00
American Well (AMWL) United States $0.154B 0.00
Outset Medical (OM) United States $0.147B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
Augmedix (AUGX) United States $0.124B 0.00
TruBridge (TBRG) United States $0.118B 5.04
111 (YI) China $0.088B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
Movano (MOVE) United States $0.048B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Akili (AKLI) United States $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.025B 0.00
Cue Health (HLTH) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00